Quality of life in adults with phenylketonuria:a systematic review / Qualidade de vida em adultos com fenilcetonúria:uma revisão sistemática
DOI:
https://doi.org/10.34117/bjdv8n3-428Keywords:
fenilcetonúria, qualidade de vida, adulto, revisão de literatura.Abstract
Objective: To evaluate the quality of life of adults with phenylketonuria (PKU) using different methodologies. Methods: review developed according to PRISMA report items and the guidelines of the Cochrane Handbook for Systematic Reviews. Research was performed in PubMed, EMBASE, BVS, SCOPUS and Cochrane Library databases in November 2021. Results: 500 articles were identified and following the inclusion and exclusion criteria, 09 selected studies evaluated 452 adults, with average age of 28 years old. 89% of the articles considered the sample insufficient, 66.6% used generic questionnaires and the remaining 33.3% used the specific questionnaire (PKU-QoL). Conclusion: The results of the impact of PKU on HRQoL were mostly positive. More research using PKU-QoL is needed to broaden the interpretation of data and expand knowledge on this topic, the development of robust studies will provide a conclusion on the effect of PKU and its treatment on HRQoL.
References
van Spronsen FJ, Blau N, Harding C, Burlina A, Longo N, Bosch AM. Phenylketonuria. Nat Rev Dis Prim [Internet]. 2021 Dec 20;7(1):36. Available from: http://www.nature.com/articles/s41572-021-00267-0
van Wegberg AMJJ, MacDonald A, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis [Internet]. 2017 Dec 12;12(1):162. Available from: http://ojrd.biomedcentral.com/articles/10.1186/s13023-017-0685-2
Castro G, Hamilton V, Cornejo V. Chilean Nutrition Management Protocol for Patients With Phenylketonuria. J Inborn Errors Metab Screen [Internet]. 2017 Jan 7;5:232640981668978. Available from: http://journals.sagepub.com/doi/10.1177/2326409816689788
Marqui ABT de. Overview of neonatal screening for phenylketonuria in Brazil. Med (Ribeirao Preto Online) [Internet]. 2016 Dec 8;49(6):517. Available from: http://revistas.usp.br/rmrp/article/view/127440
MacDonald A, van Wegberg AMJJ, Ahring K, Beblo S, Bélanger-Quintana A, Burlina A, et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis [Internet]. 2020 Dec 4;15(1):171. Available from: https://ojrd.biomedcentral.com/articles/10.1186/s13023-020-01391-y
Brasil. Protocolo Clínico e Diretrizes Terapêuticas da Fenilcetonúria [recurso eletrônico] [Internet]. Portaria Conjunta SAES/SCTIE no 12 de 10 de setembro de 2019, editor. Brasília: Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde.; 2020. 42 p. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/protocolo_clinico_diretrizes_terapeuticas_fenilcetonuria.pdf
Trefz FK, van Spronsen FJ, MacDonald A, Feillet F, Muntau AC, Belanger-Quintana A, et al. Management of adult patients with phenylketonuria: survey results from 24 countries. Eur J Pediatr [Internet]. 2015 Jan 6;174(1):119–27. Available from: http://link.springer.com/10.1007/s00431-014-2458-4
Ceberio L, Hermida Á, Venegas E, Arrieta F, Morales M, Forga M, et al. Phenylketonuria in the adult patient. Expert Opin Orphan Drugs [Internet]. 2019 Jun 3;7(6):265–76. Available from: https://www.tandfonline.com/doi/full/10.1080/21678707.2019.1633914
Demirdas S, Maurice-Stam H, Boelen CCA, Hofstede FC, Janssen MCH, Langendonk JG, et al. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study. Mol Genet Metab [Internet]. 2013;110:S49–56. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1096719213003272
Klimek A, Baerwald C, Schwarz M, Rutsch F, Parhofer KG, Plöckinger U, et al. Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study. Ann Nutr Metab [Internet]. 2020;76(4):251–8. Available from: https://www.karger.com/Article/FullText/510260
Burlina AP, Lachmann RH, Manara R, Cazzorla C, Celato A, van Spronsen FJ, et al. The neurological and psychological phenotype of adult patients with early‐treated phenylketonuria: A systematic review. J Inherit Metab Dis [Internet]. 2019 Mar 12;42(2):209–19. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jimd.12065
Bosch AM, Burlina A, Cunningham A, Bettiol E, Moreau-Stucker F, Koledova E, et al. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries. Orphanet J Rare Dis [Internet]. 2015 Dec 18;10(1):80. Available from: http://www.ojrd.com/content/10/1/80
Vieira Neto E, Maia Filho HS, Monteiro CB, Carvalho LM, Tonon T, Vanz AP, et al. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients. Brazilian J Med Biol Res [Internet]. 2018;51(2). Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000200613&tlng=en
Vicente F, Jurecki E, Giovannetti D, Ferreira AR, Leite E, Giugliani L, et al. Linguistic Validation of the Phenylketonuria - Quality of Life (PKU-QOL) Questionnaire Into Brazilian Portuguese. J Inborn Errors Metab Screen [Internet]. 2019 [cited 2020 Sep 6];7. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942019000100301&tlng=en
Bickel H, Gerrard J, Hickmans E. Preliminary Communication. Lancet [Internet]. 1953 Oct;262(6790):812–3. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673653904735
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med [Internet]. 2009 Jul 21;6(7):e1000100. Available from: https://dx.plos.org/10.1371/journal.pmed.1000100
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021 Mar 29;n71. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.n71
Landis JR, Koch GG. The Measurement of Observer Agreement for Categorical Data. Biometrics [Internet]. 1977 Mar;33(1):159. Available from: https://www.jstor.org/stable/2529310?origin=crossref
Malta M, Cardoso LO, Bastos FI, Magnanini MMF, Silva CMFP da. Iniciativa STROBE: subsídios para a comunicação de estudos observacionais. Rev Saude Publica [Internet]. 2010 Jun;44(3):559–65. Available from: https://doi.org/10.1590/S0034-89102010000300021
van Spronsen FJ, Bélanger-Quintana A. Outcomes of Phenylketonuria with Relevance to Follow-Up. In 2011. p. 49–55. Available from: http://link.springer.com/10.1007/8904_2011_16
van Spronsen FJ, Burgard P. The truth of treating patients with phenylketonuria after childhood: The need for a new guideline. J Inherit Metab Dis [Internet]. 2008 Dec 12;31(6):673–9. Available from: http://doi.wiley.com/10.1007/s10545-008-0918-6
Gassió R, Campistol J, Vilaseca M, Lambruschini N, Cambra F, Fusté E. Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatr [Internet]. 2007 Jan 2;92(12):1474–8. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1651-2227.2003.tb00834.x
Cazzorla C, Cegolon L, Burlina AP, Celato A, Massa P, Giordano L, et al. Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria. BMC Public Health [Internet]. 2014 Dec 4;14(1):1243. Available from: https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-1243
Simon E, Schwarz M, Roos J, Dragano N, Geraedts M, Siegrist J, et al. Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes [Internet]. 2008;6. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L351587058&from=export
Alptekin IM, Koc N, Gunduz M, Cakiroglu FP. The impact of phenylketonuria on PKU patients’ quality of life: Using of the phenylketonuria-quality of life (PKU-QOL) questionnaires. Clin Nutr ESPEN [Internet]. 2018 Oct;27:79–85. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2405457718303577
Barta AG, Sumánszki C, Turgonyi Z, Kiss E, Simon E, Serfőző C, et al. Health Related Quality of Life assessment among early-treated Hungarian adult PKU patients using the PKU-QOL adult questionnaire. Mol Genet Metab Reports [Internet]. 2020 Jun;23:100589. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083463598&doi=10.1016%2Fj.ymgmr.2020.100589&partnerID=40&md5=6a5a5e40c42f2ad1e45d1741128779c4
Huijbregts SCJ, Bosch AM, Simons QA, Jahja R, Brouwers MCGJ, De Sonneville LMJ, et al. The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: A PKU-COBESO study. Mol Genet Metab [Internet]. 2018 Sep;125(1–2):96–103. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1096719218302749
Bosch AM, Tybout W, Spronsen FJ van, Valk HW de, Wijburg FA, Grootenhuis MA. The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis [Internet]. 2007 Feb 11;30(1):29–34. Available from: http://doi.wiley.com/10.1007/s10545-006-0433-6
Bik-Multanowski M, Didycz B, Mozrzymas R, Nowacka M, Kaluzny L, Cichy W, et al. Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis [Internet]. 2008 Dec 29;31(S2):415–8. Available from: http://doi.wiley.com/10.1007/s10545-008-0978-7
Yin S, Njai R, Barker L, Siegel PZ, Liao Y. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model. Popul Health Metr [Internet]. 2016 Dec 11;14(1):22. Available from: http://pophealthmetrics.biomedcentral.com/articles/10.1186/s12963-016-0091-3
Jurecki E, Cunningham A, Birardi V, Gagol G, Acquadro C. Development of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaire. Health Qual Life Outcomes [Internet]. 2017;15(1). Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L614703381&from=export
Vockley, J., Andersson, H. C., Antshel, K. M., Braverman, N. E., Burton, B. K., Frazier, D. M., … Berry SA. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med [Internet]. 2014 Feb 10;16(2):188–200. Available from: http://www.nature.com/articles/gim2013157
Schmidt E, Burgard P, Rupp A. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria. Eur J Pediatr [Internet]. 1996 Jan;155(S1):S82–6. Available from: http://link.springer.com/10.1007/PL00014258
ten Hoedt AE, de Sonneville LMJ, Francois B, ter Horst NM, Janssen MCH, Rubio-Gozalbo ME, et al. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial. J Inherit Metab Dis [Internet]. 2011 Feb 10;34(1):165–71. Available from: http://doi.wiley.com/10.1007/s10545-010-9253-9
Gentile JK, Ten Hoedt AE, Bosch AM. Psychosocial aspects of PKU: Hidden disabilities – A review☆. Mol Genet Metab [Internet]. 2010;99:S64–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1096719209004764
Erlandsen H, Stevens RC. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria. J Inherit Metab Dis [Internet]. 2001 Apr;24(2):213–30. Available from: http://doi.wiley.com/10.1023/A%3A1010371002631
White DA, Antenor-Dorsey JA V., Grange DK, Hershey T, Rutlin J, Shimony JS, et al. White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria. Mol Genet Metab [Internet]. 2013 Nov;110(3):213–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1096719213002552
Martins AM, Pessoa ALS, Quesada AA, Ribeiro EM. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers. Mol Genet Metab Reports. 2020;24(May).
Burton BK, Leviton L, Vespa H, Coon H, Longo N, Lundy BD, et al. A diversified approach for PKU treatment: Routine screening yields high incidence of psychiatric distress in phenylketonuria clinics. Mol Genet Metab [Internet]. 2013 Jan;108(1):8–12. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1096719212004131
Brumm VL, Bilder D, Waisbren SE. Psychiatric symptoms and disorders in phenylketonuria☆. Mol Genet Metab [Internet]. 2010;99:S59–63. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1096719209004752
Gambol PJ. Maternal Phenylketonuria Syndrome and Case Management Implications. J Pediatr Nurs [Internet]. 2007 Apr;22(2):129–38. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0882596306003320
